Resources
EIDHS Project Fact Sheets
Joint External Evaluation Tool | WHO
The first edition of the WHO Joint External Evaluation (JEE) tool was made available in February 2016, and by the end of December 2017 67 countries had requested a JEE to WHO and completed the voluntary evaluation using this tool.
Global Health Security Agenda 2024 Framework | GHSA Steering Group
In accordance with the 2017 Kampala Declaration, which extended GHSA’s mandate by 5 years, the GHSA Steering Group leda consultative process todevelop a framework for the second phaseof GHSA, termed “GHSA 2024.” The GHSA 2024 Framework provides a high-level view of the context for GHSA’s goals and objectives for 2019-2024 and an outline of how GHSA will operate and track progress to achieve these goals. As needed, the GHSA Steering Group will consider changes to the Framework. The Steering Group will conduct a consultation with the GHSA-wide communityon any proposed changes.
Global Health Security Agenda Website | CDC
Global health security is the existence of strong and resilient public health systems that can prevent, detect, and respond to infectious disease threats, wherever they occur in the world. The Centers for Disease Control and Prevention (CDC) works 24/7 to protect the health, safety, and security of the American people and fight global health threats worldwide, so we don’t have to fight them here at home. CDC’s global health security work is carried out collaboratively by four CDC centers: The Center for Global Health, the National Center for Emerging and Zoonotic Infectious Diseases, the National Center for Immunization and Respiratory Diseases, and the Center for Preparedness and Response. In today’s globalized society, a disease threat anywhere is a disease threat everywhere.
Global Antimicrobial Resistance Surveillance System | WHO
Antimicrobial resistance (AMR) is a serious threat to global public health. In 2015, WHO launched the Global Antimicrobial Resistance Surveillance System (GLASS) in order to standardize the collection of data on AMR in Member States, for planning, prevention and intervention programmes. Reports to GLASS currently rely on detection of phenotypic resistance, which requires bacteria to be cultured and tested for growth in the presence of antimicrobial agents. In future, GLASS may incorporate the results of molecular testing for AMR detection by appropriate methods. Molecular diagnostic methods can be used at the same time as phenotypic testing to yield additional information, such as the exact gene or mutation underlying a resistance phenotype. This informationcan be used to interpret AMR profiles at surveillance sites and better understand the global occurrence of certain resistance mechanisms.
Operational Handbook on TB | WHO
This guide was developed to assist with the translation of WHO policies on tuberculosis (TB) diagnostic testing into practical guidance on the implementation of WHO-recommended tests and algorithms for TBtesting.
Consolidated Guidelines on TB | WHO
The political declaration at the first United Nations (UN) high-level meeting on tuberculosis (TB) held on 26 September 2018 included commitments by Member States to four new global targets.3 One of these targets is to diagnose and treat 40 million people with TB in the 5-year period 2018–2022. The approximate breakdown of the target is about 7 million in 2018 and about 8 million in subsequent years. The traditional method for diagnosing TB using a light microscope, developed more than 100 years ago, has in recent years been challenged by several new methods and tools. These methods are based on either the detection of mycobacterial antigens or on the detection of mycobacterial DNA.
WHO Hub for Pandemic and Epidemic Intelligence
The COVID-19 pandemic has given us a shared experience that shows how interconnected our lives are and how public health depends on each one of us. The World Health Organization (WHO) envisions a world where 1 billion more people are better protected and safe from health emergencies, no matter of where they live. It strives to increase equity in access to health care. To better address pandemic and epidemic risks, the WHO Hub for Pandemic and Epidemic Intelligence will strengthen intelligence specifically for pandemics and epidemics by striving for better data, better analytics, and better decisions. Embedded in WHO’s Health Emergencies Programme and building on consultations with hundreds of experts from different disciplines, sectors, and regions, it will leverage WHO’s unique convening power across nearly 200 countries to foster global solutions.
Pandemic Preparedness | World Bank
The COVID-19 pandemic has brought to the forefront the risk of major disease outbreaks and highlighted countries’ lack of preparedness to fight them. Pandemics are large disease outbreaks that affect several countries and pose major health, social, and economic risks. A quick-moving pathogen spreading across the globe has the potential to kill tens of millions of people, disrupt economies, and destabilize national security – just as COVID-19 has demonstrated. Climate change, urbanization, and the lack of water and sanitation are all factors that could contribute to fast-spreading, catastrophic outbreaks.
AMR and The World Bank | World Bank
Antimicrobials are drugs – such as antibiotics – that kill or control disease-causing microbes. Antimicrobial resistance (AMR) occurs when microbes mutate or adapt in ways that enable them to withstand antimicrobials, rendering treatments ineffective. AMR is dramatically accelerated by the over-use and misuse of antimicrobials, including antibiotics, in people and animals.
Disease Outbreak News | WHO
Latest WHO Disease Outbreak News (DONs), providing information on confirmed acute public health events or potential events of concern.